Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)

Market Cap	5.07B +64.3%
Revenue (ttm)	597.53M +5.2%
Net Income	102.75M +54.1%
EPS	0.85 +51.3%
Shares Out	120.45M
PE Ratio	49.78
Forward PE	n/a
Dividend	0.40 (0.95%)
Ex-Dividend Date	n/a

Volume	10,180,160
Average Volume	7,622,750
Open	43.05
Previous Close	43.62
Day's Range	41.43 - 43.50
52-Week Range	22.10 - 46.61
Beta	0.87
RSI	57.40
Earnings Date	Apr 25, 2026

About SHE:301509

Kingchem (Liaoning) Life Science Co., Ltd. engages in the provision of small molecule CDMO services for life science customers in China and internationally. The company offers fluorine-containing products, such as trifluoromethoxy or trifluoromethyl benzene intermediates, and fluorinated aromatic ring intermediates. It also provides non-fluorinated products, including nitrogen-containing heterocyclic series, aliphatic organic derivatives of ammonia, carboxylic acids and their derivatives, olefins, nonfluorinated halogenated benzenes, phenols, k...

• Industry: Pharmaceutical Preparations
• Founded: 2009
• Employees: 711
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301509

Financial Performance

In 2024, SHE:301509's revenue was 497.01 million, a decrease of -35.19% compared to the previous year's 766.82 million. Earnings were 38.61 million, a decrease of -77.76%.